GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Creo Medical Group PLC (LSE:CREO) » Definitions » Pretax Margin %

Creo Medical Group (LSE:CREO) Pretax Margin % : -74.83% (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Creo Medical Group Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Creo Medical Group's Pre-Tax Income for the six months ended in Dec. 2023 was £-11.30 Mil. Creo Medical Group's Revenue for the six months ended in Dec. 2023 was £15.10 Mil. Therefore, Creo Medical Group's pretax margin for the quarter that ended in Dec. 2023 was -74.83%.

The historical rank and industry rank for Creo Medical Group's Pretax Margin % or its related term are showing as below:

LSE:CREO' s Pretax Margin % Range Over the Past 10 Years
Min: -143192.31   Med: -120.58   Max: -79.55
Current: -79.55


LSE:CREO's Pretax Margin % is ranked worse than
74.6% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: -0.89 vs LSE:CREO: -79.55

Creo Medical Group Pretax Margin % Historical Data

The historical data trend for Creo Medical Group's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creo Medical Group Pretax Margin % Chart

Creo Medical Group Annual Data
Trend Feb14 Feb15 Feb16 Jun17 Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only -143,192.31 -248.83 -120.58 -113.60 -79.55

Creo Medical Group Semi-Annual Data
Feb14 Feb15 Feb16 Dec16 Jun17 Dec17 Jun18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -154.40 -118.38 -108.82 -84.08 -74.83

Competitive Comparison of Creo Medical Group's Pretax Margin %

For the Medical Devices subindustry, Creo Medical Group's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Creo Medical Group's Pretax Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Creo Medical Group's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Creo Medical Group's Pretax Margin % falls into.



Creo Medical Group Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Creo Medical Group's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-24.5/30.8
=-79.55 %

Creo Medical Group's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-11.3/15.1
=-74.83 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Creo Medical Group  (LSE:CREO) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Creo Medical Group Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Creo Medical Group's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Creo Medical Group (LSE:CREO) Business Description

Traded in Other Exchanges
N/A
Address
Beaufort Park Way, Unit 2, Creo House, Beaufort Park, Chepstow, GBR, NP16 5UH
Creo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called Croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency through a single accessory port. The reportable segment of the company is the research and development of electrosurgical medical devices relating to the field of surgical endoscopy.

Creo Medical Group (LSE:CREO) Headlines

No Headlines